The anti-fibrotic agent nintedanib protects chondrocytes against tumor necrosis factor-ɑ (TNF-ɑ)-induced extracellular matrix degradation

References

• Pereira D, Ramos E, Branco J. Osteoarthritis. Acta Med Port. 2015;28:99–106.
   PubMed Web of Science ®Google Scholar
• Geyer M, Schonfeld C. Novel insights into the pathogenesis of osteoarthritis. Curr Rheumatol Rev. 2018;14(2):98–107.
   PubMed Web of Science ®Google Scholar
• Becerra J, Andrades JA, Guerado E, et al. Articular cartilage: structure and regeneration. Tissue Eng Part B Rev. 2010;16(6):617–627.
   PubMed Web of Science ®Google Scholar
• Charlier E, Deroyer C, Ciregia F, et al. Chondrocyte dedifferentiation and osteoarthritis (OA). Biochem Pharmacol. 2019;165:49–65.
   PubMed Web of Science ®Google Scholar
• Fosang AJ, Beier F. Emerging frontiers in cartilage and chondrocyte biology. Best Pract Res Clin Rheumatol. 2011;25(6):751–766.
   PubMed Web of Science ®Google Scholar
• Charlier E, Relic B, Deroyer C, et al. Insights on molecular mechanisms of chondrocytes death in osteoarthritis. Int J Mol Sci. 2016;17(12):2146.
   PubMed Web of Science ®Google Scholar
• Trachana V, Mourmoura E, Papathanasiou I, et al. Understanding the role of chondrocytes in osteoarthritis: utilizing proteomics. Expert Rev Proteomics. 2019;16(3):201–213.
   PubMed Web of Science ®Google Scholar
• How CW, Ong YS, Low SS, et al. How far have we explored fungi to fight cancer? Semin Cancer Biol. 2021;S1044-579X(21)00059–6.
   PubMed Web of Science ®Google Scholar
• Looi QH, Foo JB, Lim MT, et al. How far have we reached in development of effective influenza vaccine? Int Rev Immunol. 2018;37(5):266–276.
   PubMed Web of Science ®Google Scholar
• Tan KL, Chia WC, How CW, et al. Benchtop isolation and characterisation of small extracellular vesicles from human mesenchymal stem cells. Mol Biotechnol. 2021;63(9):780–791.
   PubMed Web of Science ®Google Scholar
• Kuwana M, Azuma A. Nintedanib: new indication for systemic sclerosis-associated interstitial lung disease. Mod Rheumatol. 2020;30(2):225–231.
   PubMed Web of Science ®Google Scholar
• Wollin L, Maillet I, Quesniaux V, et al. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. J Pharmacol Exp Ther. 2014;349(2):209–220.
   PubMed Web of Science ®Google Scholar
• Lee J, Rhee CK, Lee JH, et al. Effect of nintedanib on airway inflammation in a mouse model of acute asthma. J Asthma. 2020;57(1):11–20.
   PubMed Web of Science ®Google Scholar
• Redente EF, Aguilar MA, Black BP, et al. Nintedanib reduces pulmonary fibrosis in a model of rheumatoid arthritis-associated interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2018;314(6):L998–L1009.
   PubMed Web of Science ®Google Scholar
• Shi JM, Cao FY, Chang YJ, et al. Long non-coding RNA MCM3AP-AS1 protects chondrocytes ATDC5 and CHON-001 from IL-1β-induced inflammation via regulating miR-138-5p/SIRT1. Bioengineered. 2021;12(1):1445–1456.
   PubMed Web of Science ®Google Scholar
• Qi H, Zhang JC, Shang Y, et al. Argon inhibits reactive oxygen species oxidative stress via the miR-21-mediated PDCD4/PTEN pathway to prevent myocardial ischemia/reperfusion injury. Bioengineered. 2021;12(1):5529–5539.
   PubMed Web of Science ®Google Scholar
• Wang X, Fan J, Ding X, et al. Tanshinone I inhibits IL-1β- induced apoptosis, inflammation, and extracellular matrix degradation in chondrocytes CHON-001 cells and attenuates murine osteoarthritis. Drug Des Dev Ther. 2019;13:3559–3568.
   PubMed Web of Science ®Google Scholar
• Wollin L, Togbe D, Ryffel B. Effects of nintedanib in an animal model of liver fibrosis. Biomed Res Int. 2020;2020:3867198.
   PubMed Web of Science ®Google Scholar
• Liu F, Yu C, and Qin H, et al. Nintedanib attenuates peritoneal fibrosis by inhibiting mesothelial-to-mesenchymal transition, inflammation and angiogenesis. J Cell Mol Med. 2021;25(13):6103–6114.
   Web of Science ®Google Scholar
• Li X, Xi B, Miao Y, et al. Nintedanib ameliorates imiquimod-induced psoriasis in mice by inhibiting NF-kappaB and VEGFR2 signaling. Int Immunopharmacol. 2021;100:108129.
   PubMed Web of Science ®Google Scholar
• Liu F, Wang L, Qi H, et al. Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease. Clin Sci (Lond). 2017;131(16):2125–2143.
   PubMed Web of Science ®Google Scholar
• Boxhammer E, Lehle K, Schmid C, et al. Anti-oxidative effect of the tyrosine kinase inhibitor nintedanib: a potential therapy for chronic lung allograft dysfunction? Exp Lung Res. 2020;46(5):128–145.
   PubMed Web of Science ®Google Scholar
• Fois AG, Sotgiu E, and Scano V, et al. Effects of pirfenidone and nintedanib on markers of systemic oxidative stress and inflammation in patients with idiopathic pulmonary fibrosis: a preliminary report. Antioxidants (Basel). 2020;9:1064.
   PubMedGoogle Scholar
• Ansari MY, Ahmad N, Haqqi TM. Oxidative stress and inflammation in osteoarthritis pathogenesis: role of polyphenols. Biomed Pharmacother. 2020;129:110452.
   PubMed Web of Science ®Google Scholar
• Lepetsos P, Papavassiliou AG. ROS/oxidative stress signaling in osteoarthritis. Biochim Biophys Acta. 2016;1862:576–591.
   PubMed Web of Science ®Google Scholar
• Shen J, Abu-Amer Y, O’Keefe RJ, et al. Inflammation and epigenetic regulation in osteoarthritis. Connect Tissue Res. 2017;58:49–63.
   PubMed Web of Science ®Google Scholar
• de Crombrugghe B, Lefebvre V, Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol. 2001;13(6):721–727.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Eberspaecher H, Lefebvre V, et al. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn. 1997;209:377–386.
   PubMed Web of Science ®Google Scholar
• Sekiya I, Tsuji K, Koopman P, et al. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem. 2000;275(15):10738–10744.
   PubMed Web of Science ®Google Scholar
• Orfanidou T, Iliopoulos D, Malizos KN, et al. Involvement of SOX-9 and FGF-23 in RUNX-2 regulation in osteoarthritic chondrocytes. J Cell Mol Med. 2009;13:3186–3194.
   PubMed Web of Science ®Google Scholar
• Tasken K, Aandahl EM. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev. 2004;84(1):137–167.
   PubMed Web of Science ®Google Scholar
• Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001;2(8):599–609.
   PubMed Web of Science ®Google Scholar
• Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem. 1999;68(1):821–861.
   PubMedGoogle Scholar
• Wang L, Feng L, Zhang J. Liraglutide exhibits anti-inflammatory activity through the activation of the PKA/CREB pathway. J Inflamm (Lond). 2019;16(1):21.
   PubMed Web of Science ®Google Scholar
• Guo J, Li Y, Zhao R, et al. Adipokine zinc-alpha2-glycoprotein alleviates lipopolysaccharide-induced inflammatory responses through the beta3-AR/PKA/CREB pathway. Cytokine. 2019;123:154742.
   PubMed Web of Science ®Google Scholar
• Li H, Li J, Zhang X, et al. DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling. Biochem Pharmacol. 2020;177:113958.
   PubMed Web of Science ®Google Scholar
• Que Q, Guo X, Zhan L, et al. The GLP-1 agonist, liraglutide, ameliorates inflammation through the activation of the PKA/CREB pathway in a rat model of knee osteoarthritis. J Inflamm (Lond). 2019;16(1):13.
   PubMedGoogle Scholar
• Zhang M, Wang Y, Huan Z, et al. FSH modulated cartilage ECM metabolism by targeting the PKA/CREB/SOX9 pathway. J Bone Miner Metab. 2021;39(5):769–779.
   PubMed Web of Science ®Google Scholar
• Juhász T, Matta C, Somogyi C, et al. Mechanical loading stimulates chondrogenesis via the PKA/CREB-Sox9 and PP2A pathways in chicken micromass cultures. Cell Signal. 2014 Mar;26(3):468–482.
   PubMed Web of Science ®Google Scholar